Screener
PTC Therapeutics PTCT Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001070081-26-000012
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Trade and royalty receivables, net | 219,919 | 181,621 |
| Inventory, net | 75,567 | 79,647 |
| Prepaid expenses and other current assets | 66,054 | 67,309 |
| Total current assets | 2,254,003 | 2,273,948 |
| Fixed assets, net | 52,739 | 55,371 |
| Intangible assets, net | 380,684 | 388,753 |
| Goodwill | 82,341 | 82,341 |
| Operating lease ROU assets | 76,692 | 80,053 |
Item 1. Financial Statements (unaudited)
FAQ
- What is PTC Therapeutics's total current assets?
- PTC Therapeutics (PTCT) reported total current assets of $2.25B in Q1 2026.
- How has PTC Therapeutics's total current assets changed year-over-year?
- PTC Therapeutics's total current assets decreased by 2.7% year-over-year, from $2.32B to $2.25B.
- What is the long-term trend for PTC Therapeutics's total current assets?
- Over 5 years (2020 to 2025), PTC Therapeutics's total current assets has grown at a 13.0% compound annual growth rate (CAGR), from $1.23B to $2.27B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about PTC Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude